Frontiers in Endocrinology (Dec 2022)

The selective aldosterone synthase inhibitor Baxdrostat significantly lowers blood pressure in patients with resistant hypertension

  • Imma Forzano,
  • Pasquale Mone,
  • Fahimeh Varzideh,
  • Stanislovas S. Jankauskas,
  • Urna Kansakar,
  • Antonio De Luca,
  • Gaetano Santulli,
  • Gaetano Santulli

DOI
https://doi.org/10.3389/fendo.2022.1097968
Journal volume & issue
Vol. 13

Abstract

Read online

No abstracts available.

Keywords